85 related articles for article (PubMed ID: 19481913)
1. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.
Ronconi V; Turchi F; Rilli S; Di Mattia D; Agostinelli L; Boscaro M; Giacchetti G
Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):93-100. PubMed ID: 19481913
[TBL] [Abstract][Full Text] [Related]
2. Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess.
Tapia-Castillo A; Carvajal CA; Pérez JA; Fardella CE
Endocrine; 2022 Aug; 77(2):380-391. PubMed ID: 35676467
[TBL] [Abstract][Full Text] [Related]
3. Obesity-associated genetic variants in young Asian Indians with the metabolic syndrome and myocardial infarction.
Ranjith N; Pegoraro RJ; Shanmugam R
Cardiovasc J Afr; 2011; 22(1):25-30. PubMed ID: 21298202
[TBL] [Abstract][Full Text] [Related]
4. Genetic Risk of Primary Aldosteronism and Its Contribution to Hypertension: A Cross-Ancestry Meta-Analysis of Genome-Wide Association Studies.
Naito T; Inoue K; Sonehara K; Baba R; Kodama T; Otagaki Y; Okada A; Itcho K; Kobuke K; Kishimoto S; Yamamoto K; ; Morisaki T; Higashi Y; Hinata N; Arihiro K; Hattori N; Okada Y; Oki K
Circulation; 2023 Apr; 147(14):1097-1109. PubMed ID: 36802911
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Clinical Features between Primary Aldosteronism and Essential Hypertension in Chinese Patients: A Case-Control Study.
Huang X; Yu S; Xiao H; Pei L; Chen Y; Chen W; Li Y; Xiao H; Cao X
Int J Endocrinol; 2021; 2021():6685469. PubMed ID: 34194493
[TBL] [Abstract][Full Text] [Related]
6. Differences in Glycemic Abnormalities Between Primary Aldosteronism and Essential Hypertension: A Systematic Review and Meta-Analysis.
Manosroi W; Atthakomol P; Wattanawitawas P; Buranapin S
Front Endocrinol (Lausanne); 2022; 13():870047. PubMed ID: 35432215
[TBL] [Abstract][Full Text] [Related]
7. Lipid Profiles in Primary Aldosteronism Compared with Essential Hypertension: Propensity-Score Matching Study.
Moon SJ; Jang HN; Kim JH; Moon MK
Endocrinol Metab (Seoul); 2021 Aug; 36(4):885-894. PubMed ID: 34372626
[TBL] [Abstract][Full Text] [Related]
8. Left Ventricular Remodeling in Patients with Primary Aldosteronism: A Prospective Cardiac Magnetic Resonance Imaging Study.
Wu T; Ren Y; Wang W; Cheng W; Zhou F; He S; Liu X; Li L; Tang L; Deng Q; Zhou X; Chen Y; Sun J
Korean J Radiol; 2021 Oct; 22(10):1619-1627. PubMed ID: 34269528
[TBL] [Abstract][Full Text] [Related]
9. Elevated Myoglobin in Patients With Primary Aldosteronism: A Cross-Sectional Study.
Kang B; Peng C; Wang K; Song Y; Yang Y; Ma L; Mei M; Hu J; Yang S; Wu FF; Li Q
Front Endocrinol (Lausanne); 2022; 13():799174. PubMed ID: 35265036
[TBL] [Abstract][Full Text] [Related]
10. Risk of dementia in primary aldosteronism compared with essential hypertension: a nationwide cohort study.
Hong N; Kim KJ; Yu MH; Jeong SH; Lee S; Lim JS; Rhee Y
Alzheimers Res Ther; 2023 Aug; 15(1):136. PubMed ID: 37568223
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of primary and secondary hyperparathyroidism and its cardiometabolic implications in primary aldosteronism.
Araujo-Castro M; Pascual-Corrales E; Fernández-Argüeso M; Bengoa-Rojano N; García Cano A; Jiménez Mendiguchía L; Cuesta M
Minerva Endocrinol (Torino); 2023 Dec; 48(4):401-410. PubMed ID: 37166400
[TBL] [Abstract][Full Text] [Related]
12. The Correlation Between Aldosterone and Leukocyte-Related Inflammation: A Comparison Between Patients with Primary Aldosteronism and Essential Hypertension.
Rao KR; Bao RY; Ming H; Liu JW; Dong YF
J Inflamm Res; 2023; 16():2401-2413. PubMed ID: 37304156
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Intra-Renal Stiffness in Patients with Primary Aldosteronism.
Petramala L; Concistrè A; Circosta F; Gigante A; Sarlo F; Schina M; Soldini M; Iannucci G; Cianci R; Letizia C
High Blood Press Cardiovasc Prev; 2022 Jan; 29(1):49-56. PubMed ID: 34757582
[TBL] [Abstract][Full Text] [Related]
14. Risky business: a single-centre cross-sectional analysis of calculated cardiovascular risk in patients with primary aldosteronism and essential hypertension.
Solanki P; Gwini SM; Libianto R; Gabb G; Shen J; Young MJ; Fuller PJ; Yang J
BMJ Open; 2022 Nov; 12(11):e062406. PubMed ID: 36375972
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of urinary extracellular vesicles highlights specific signatures for patients with primary aldosteronism.
Bertolone L; Castagna A; Manfredi M; De Santis D; Ambrosani F; Antinori E; Mulatero P; Danese E; Marengo E; Barberis E; Veneri M; Martinelli N; Friso S; Pizzolo F; Olivieri O
Front Endocrinol (Lausanne); 2023; 14():1096441. PubMed ID: 37223008
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics of Target Organ Damage in Primary Aldosteronism with or without Metabolic Syndrome.
Bu X; Sun F; Zhang H; Liu X; Zhao Z; He H; Li Y; Yan Z; Zhu Z
J Diabetes Res; 2022; 2022():8932133. PubMed ID: 36117521
[TBL] [Abstract][Full Text] [Related]
17. Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight.
Bioletto F; Bollati M; Lopez C; Arata S; Procopio M; Ponzetto F; Ghigo E; Maccario M; Parasiliti-Caprino M
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563192
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors Associated With Lower Bone Mineral Density in Primary Aldosteronism Patients.
Lv X; Hu H; Shen C; Zhang X; Yan L; Zhang S; Guo Y
Front Endocrinol (Lausanne); 2022; 13():884302. PubMed ID: 35784563
[TBL] [Abstract][Full Text] [Related]
19. Platelet Cyclic GMP Levels Are Reduced in Patients with Primary Aldosteronism.
Sala C; Rescaldani M; Gherbesi E; Bolla G; Cuspidi C; Ruscica M; Carugo S
J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002693
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin and Interleukin-33: Possible Early Markers of Metabolic Syndrome.
Nesic J; Ljujic B; Rosic V; Djukic A; Rosic M; Petrovic I; Zornic N; Jovanovic IP; Petrovic S; Djukic S
J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
